for comment on a policy-related story, email us at media.contact@policycn.com

Chinas Bauern profitieren nicht vom Aufschwung

Although state media only report the program's major successes, it will remain a pilot project in the future, only covering a few areas around Beijing and Tianjin. For good reason, says Even Pay from Beijing research advisory China Policy. After all, it has only produced modest results: on the one hand it has provided many farmers urgently needed money for investments, but on the other hand the formalities are so complicated that several have already failed at the application process, criticises Pay. Moreover, banks lack the required knowledge to correctly assess the situation of farmers.

emboldened by a strengthening economy, China flexes its diplomatic muscles

Still, there is debate about the sustainability of China's economic growth and its capacity for global leadership, David Kelly, a director of research at the Beijing-based advisory firm China Policy, observes. "If you speed up very fast," Kelly says, "you find that you're up against a barrier of other powers bandwagoning against you" — resulting in diplomatic isolation. "The sustainability of wealth and power is very much up for debate," he says. Assumptions about China's future economic strength rest on the country's past success in meeting U.S. and European manufacturing needs of the 1990s and 2000s. In other words, "That growth was based on the world economy at that time," he says, "and it's no longer the same world economy."

trials in pharmaceutical innovation

A new and simplified approval process is making it easier for foreign firms to sell pharmaceuticals and medical devices in China. This is a shift from the country’s previous requirement for separate trials, which discouraged and delayed the launch of new products by foreign pharmaceutical firms on the Chinese market. To be eligible for faster pharmaceutical authorisation, foreign firms need to include Chinese people in their international multi-centre trials (IMCTs). Jeroen Groenewegen, Amy Mao and Xu Meiying from China Policy argue that this new trial system changes China’s research and development (R&D) system with it having better access to international clinical data, research facilities, testing populations and investment.

echoes of Mao: China Communist Party fawns over ‘Xi thought’

Xi is already expected to use the congress to stack the top echelons of party leadership with loyalists. But adding his name to the party's commandments would show that 'he has turned the page' on Chinese history, said David Kelly, director of research at Beijing-based consultancy China Policy. 'It's his assertion that "on my watch, we became a major power," which is something Mao could not claim,' he said.

revised subsidy to keep Chinese EV carmakers afloat

'The government decided to cut subsidies gradually to allow the industry to stand on its own, as it was heavily reliant on subsidies previously,' said Cao Nanxin, a senior industry analyst at research advisory China Policy, headquartered in Beijing. EVs are also part of a grander plan by China to burnish the image of “Made in China” and transform itself from a producer of cheap goods into an economy of value-added industries, Cao said.

at China’s Party Congress, all eyes will be on Xi Jinping

David Kelly, director of research at China Policy in Beijing, says Xi claims to have higher levels of support than even his predecessors. 'He (Mao) was important ... he was taken seriously, but China remained a client state of the Soviet Union. Perhaps you can say he was the leader of a developing country, but you could not say he was the leader of a major power as Xi is.'

thinking the unthinkable in China: abandoning North Korea

David Kelly, director of research at Beijing-based consultancy China Policy, said the thinking among Chinese academics was: 'We could do better without them, a unified Korea would be incredibly good for China, the northeast would boom'.

UBS report says Chinese unicorns are on the rise

Analyst Jeroen Groenewegen, with Beijing based research company China Policy, told The Australian that the core issue in assessing China’s likely success at innovation was “whether you believe such top-down planning can generate innovation, and if so, what kind”. The Chinese state is indeed investing heavily, both economically and politically, he said, and had been for more than a decade. Because its returns had been comparatively modest, he said, the state was adjusting its support to incentivise the kind of indices that UBS highlights in its report, especially patents, scientific publications and university programs.

China’s National Congress prepares to shuffle the deck in second-largest economy

China Policy's David Kelly, an Australian who has been observing Chinese politics for 40 years, says he no longer watches for factions but rather where people sit along an "axis of risk aversion", to guess who Xi will want to work with. Who in the party thinks China should push onto the world stage faster? Who wants a more cautious approach?

Doklam pact as big publicity loss: analyst

Many among the Chinese elite and party rank and file were not in favour of going for the agreement on troop withdrawal after weeks of the border standoff, David Kelly, research director at Beijing-based consultancy China Policy, said in his lecture here on Tuesday evening. Kelly said, "It (border agreement) is a big publicity loss... The newspaper-reading public is not satisfied. Readers believe that if the PLA can attack, it should attack".

China’s struggles to attract foreign investment

Grasping how the use of ‘negative lists’ is shaping governance shifts is key to successfully navigating new business opportunities in China. The regulatory environment has changed slowly since the 2013 Third Plenum declaration of a more open and inviting investment atmosphere, but has sped up notably in 2017. Now more than ever, knowing all the facts and status of reform can make an immense difference to business operations. Philippa Jones and Erlend Ek from China Policy help to untangle China’s changing trade policy and clarify how China’s new regulations are supporting its bid to become a champion of globalised trade.

analysts: amendments to China’s constitution to include Xi Jinping Thought

Since Mao Zedong ruled China, the key thoughts, ideas and ideals of the country’s Communist Party’s leaders have been added to its body’s constitution as it has single-handedly ruled one of the world’s most populous nations. But not all have had their names tagged on to their ideals. The practice is something like President Franklin D. Roosevelt’s New Deal, said David Kelly, director of research at China Policy, a Beijing-based consulting company. “[When] you think of Roosevelt, you think New Deal,” he said. “Powerful people want to leave these monuments behind as their legacy. To have that, it extends the lifetime of their political influence.”